Strength Seen in Apricus Biosciences (APRI): Stock Soars 18.9% - Tale of the Tape - Enanta Pharma (NASDAQ:ENTA)

Apricus Biosciences, Inc. APRI was a big mover last session, as the company saw its shares rise almost 19% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company, as the stock is now down more than 9% in the past one-month time frame.

The company has seen one positive and one negative estimate revision in the past 30 days, while its Zacks Consensus Estimate moved lower over the same time frame, suggesting trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

Apricus Biosciences currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked medical stocks include Grifols, S.A. GRFS, ImmunoGen, Inc. IMGN and Enanta Pharmaceuticals, Inc. ENTA. All these stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

APPRICUS BIOSCI APRI: Free Stock Analysis Report

ENANTA PHARMA ENTA: Free Stock Analysis Report

GRIFOLS SA-ADR GRFS: Free Stock Analysis Report

IMMUNOGEN INC IMGN: Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Market News and Data brought to you by Benzinga APIs